| Oct 10 |
Clearmind Medicine Announces IRB Approval for FDA First-In-Human Clinical Trial of CMND-100 at Second Clinical Site
|
| Sep 16 |
Clearmind Medicine Announces the Notice of an International Patent Application for Pioneering Ibogaine Combination Therapy
|
| Sep 12 |
Clearmind Medicine and Yissum File International Patent Application for Revolutionary Psychedelic Compounds for PTSD Treatment
|
| Sep 6 |
SciSparc-Clearmind Medicine Collaboration Leads to Publication of International Patent Application for Innovative MDMA-Based Combination Treatment
|
| Sep 6 |
Clearmind Medicine Announces Publication of International Patent Application for Innovative MDMA-Based Combination Treatment
|
| Aug 29 |
Clearmind Medicine Announces Publication of its Patent Application for Innovative Ketamine-Based Combination Treatment
|
| Aug 25 |
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
|
| Aug 21 |
Clearmind Medicine Granted U.S. Patent Approval for Binge Behavior Treatment
|
| Aug 16 |
Clearmind Medicine and Yissum Expand Collaboration with International Patent Application for Generation 3.0 Psychedelic Compounds to Treat Mental Disorders
|
| Aug 9 |
Why Doximity Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket
|
